Insulin for Hyperglycemia in Stroke Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 452 participants.
Also called NCT04834362
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 452 participants
- Sponsor
- National Institute of Neurosciences and Hospital, Dhaka
- Registry
-
NCT04834362
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Bangladesh
- Registry status
- Completed
Technical summary
Registry record NCT04834362. Randomized; no masking; primary purpose treatment. Start 2021-04-05 (actual); primary completion 2021-06-20 (actual). Results posted on 2021-12-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Insulin for Hyperglycemia in Stroke Trial
- Condition
- Hyperglycemia
- Condition
- Stroke, Acute
- Intervention (Drug)
- Analog Insulin
- Intervention (Drug)
- Human insulin
- Lead sponsor
- National Institute of Neurosciences and Hospital, Dhaka
Record details
- Record id
cardio:ct-nct04834362- Content hash
07cceff8e7432065a8205100c468fd5ac2b118e5478d1a3b36ffe51759ae2e28